Sees FY24 revenue $520M-$542M, consensus $501.09M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ANIP:
- Is ANIP a Buy, Before Earnings?
- ANI Pharmaceuticals Sells Ontario Facility for $14.2M USD
- ANI Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference
- ANI Pharmaceuticals Enhances Financial Disclosure Accessibility
- ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024, at 8:30 a.m. ET